What is ALX Oncology Holdings Inc. Common Stock's Market Cap?

ALX Oncology Holdings Inc. Common Stock's Market Cap is $263.4M, based on as-reported figures from SEC (XBRL) filings.

What is ALX Oncology Holdings Inc. Common Stock's Enterprise Value?

ALX Oncology Holdings Inc. Common Stock's Enterprise Value is $136.0M, based on as-reported figures from SEC (XBRL) filings.

What is ALX Oncology Holdings Inc. Common Stock's EV / EBITDA?

ALX Oncology Holdings Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is ALX Oncology Holdings Inc. Common Stock's Net Income (TTM)?

ALX Oncology Holdings Inc. Common Stock's Net Income (TTM) is -$80.9M, based on as-reported figures from SEC (XBRL) filings.

What is ALX Oncology Holdings Inc. Common Stock's EBITDA?

ALX Oncology Holdings Inc. Common Stock's EBITDA is -$82.0M, based on as-reported figures from SEC (XBRL) filings.

What is ALX Oncology Holdings Inc. Common Stock's Diluted EPS (TTM)?

ALX Oncology Holdings Inc. Common Stock's Diluted EPS (TTM) is -0.58, based on as-reported figures from SEC (XBRL) filings.

What is ALX Oncology Holdings Inc. Common Stock's Net Debt?

ALX Oncology Holdings Inc. Common Stock's Net Debt is -$127.4M, based on as-reported figures from SEC (XBRL) filings.

ALX Oncology Holdings Inc. Common Stock (ALXO) Financial Statements

ALX Oncology Holdings Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00VR8SF73

XNAS · usd

1.91▼ 0.09 (-4.75%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close2.00

Day's Range1.96 – 2.02

52-Week Range1.01 – 2.66

Volume424.4K

Avg Volume859.1K

Share Statistics

Shares Outstanding

Employees43

ExchangeXNAS

Listed2020-07-17

Share count as of July 30, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about ALX Oncology Holdings Inc. Common Stock (ALXO)

What is ALX Oncology Holdings Inc. Common Stock's Market Cap?: ALX Oncology Holdings Inc. Common Stock's Market Cap is $263.4M, based on as-reported figures from SEC (XBRL) filings.
What is ALX Oncology Holdings Inc. Common Stock's Enterprise Value?: ALX Oncology Holdings Inc. Common Stock's Enterprise Value is $136.0M, based on as-reported figures from SEC (XBRL) filings.
What is ALX Oncology Holdings Inc. Common Stock's EV / EBITDA?: ALX Oncology Holdings Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is ALX Oncology Holdings Inc. Common Stock's Net Income (TTM)?: ALX Oncology Holdings Inc. Common Stock's Net Income (TTM) is -$80.9M, based on as-reported figures from SEC (XBRL) filings.
What is ALX Oncology Holdings Inc. Common Stock's EBITDA?: ALX Oncology Holdings Inc. Common Stock's EBITDA is -$82.0M, based on as-reported figures from SEC (XBRL) filings.
What is ALX Oncology Holdings Inc. Common Stock's Diluted EPS (TTM)?: ALX Oncology Holdings Inc. Common Stock's Diluted EPS (TTM) is -0.58, based on as-reported figures from SEC (XBRL) filings.
What is ALX Oncology Holdings Inc. Common Stock's Net Debt?: ALX Oncology Holdings Inc. Common Stock's Net Debt is -$127.4M, based on as-reported figures from SEC (XBRL) filings.